Ledger.Open graph →
SEC Form D · filed February 27, 2019

HOOKIPA Pharma Inc

Offering
Sold
$37.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Joern Aldag · NEW YORK, NYExec · DirectorChristoph Lengauer · NEW YORK, NYDirectorPaul-Henri Lambert · NEW YORK, NYDirectorJan Van De Winkel · NEW YORK, NYDirectorMichael Kelly · Medford, ORDirectorReinhard Kandera · NEW YORK, NYExec · DirectorGraziano Seghezzi · WALTHAM, MADirectorJulie O'Neill · NEW YORK, NYDirectorSander Van Deventer · NEW YORK, NYDirectorJoern Aldag · NEW YORK, NYExec · DirectorChristoph Lengauer · NEW YORK, NYDirectorPaul-Henri Lambert · NEW YORK, NYDirectorJan Van De Winkel · NEW YORK, NYDirectorMichael Kelly · Calgary, Alberta, CanadaDirectorReinhard Kandera · NEW YORK, NYExec · DirectorGraziano Seghezzi · WALTHAM, MADirectorJulie O'Neill · NEW YORK, NYDirectorSander Van Deventer · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗